These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36366400)

  • 21. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Everolimus in Modulating the Host Immune Responses against
    Raien A; Davis S; Zhang M; Zitser D; Lin M; Pitcher G; Bhalodia K; Subbian S; Venketaraman V
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    P M; Ahmad J; Samal J; Sheikh JA; Arora SK; Khubaib M; Aggarwal H; Kumari I; Luthra K; Rahman SA; Hasnain SE; Ehtesham NZ
    Front Immunol; 2021; 12():706081. PubMed ID: 34386011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal Glutathione Helps to Mitigate
    Kachour N; Beever A; Owens J; Cao R; Kolloli A; Kumar R; Sasaninia K; Vaughn C; Singh M; Truong E; Khatchadourian C; Sisliyan C; Zakery K; Khamas W; Subbian S; Venketaraman V
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453358
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunologic Role of Innate Lymphoid Cells against
    Narinyan W; Poladian N; Orujyan D; Gargaloyan A; Venketaraman V
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trained immunity contributes to the prevention of
    Zhou J; Lv J; Carlson C; Liu H; Wang H; Xu T; Wu F; Song C; Wang X; Wang T; Qian Z
    Emerg Microbes Infect; 2021 Dec; 10(1):578-588. PubMed ID: 33666534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2.
    Gu X; Gao Y; Mu DG; Fu EQ
    Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in
    Cerni S; Shafer D; To K; Venketaraman V
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunology of tuberculosis and cytokines].
    Tsuyuguchi I
    Kekkaku; 1995 May; 70(5):335-46. PubMed ID: 7783394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    Singh B; Saqib M; Gupta A; Kumar P; Bhaskar S
    PLoS One; 2017; 12(12):e0189606. PubMed ID: 29236768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy.
    Gonzalez-Orozco M; Strong EJ; Paroha R; Lee S
    BMC Immunol; 2022 Sep; 23(1):43. PubMed ID: 36104771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
    Pi J; Zhang Z; Yang E; Chen L; Zeng L; Chen Y; Wang R; Huang D; Fan S; Lin W; Shen H; Xu JF; Zeng G; Shen L
    J Nanobiotechnology; 2022 Jan; 20(1):36. PubMed ID: 35033108
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.